Investment Thesis
Vicarious Surgical is a pre-revenue or near-zero revenue company burning approximately $45M in operating cash annually against only $2.6M in cash reserves, creating a critical liquidity crisis. With persistent operating losses of $50M, negative profitability across all metrics, and a cash runway of less than one month at current burn rates, the company faces imminent insolvency without significant capital infusion or immediate path to profitability.
Strengths
- Low debt-to-equity ratio of 0.20x provides limited financial flexibility
- Operates in surgical supplies sector (SIC 3842) with long-term market potential
- Current ratio of 2.97x indicates adequate short-term asset coverage on balance sheet
Risks
- No revenue generation reported - company appears pre-commercial or non-viable
- Catastrophic cash burn of $45.1M operating cash flow against $2.6M cash on hand (sub-one-month runway)
- Persistent $50M+ operating losses with zero path to profitability demonstrated
- Negative ROE (-509.9%) and ROA (-256.3%) indicate severe asset utilization failure
- EPS deteriorated 1,325% YoY, signaling worsening financial condition
- Minimal insider activity (2 filings/90 days) suggests limited management confidence
Key Metrics to Watch
- Days of cash remaining and any capital raise announcements
- Quarterly revenue achievement or first revenue milestone
- Operating cash burn rate trajectory and path to cash flow positive
- Form 8-K filings for material adverse changes or going concern warnings
Financial Metrics
Revenue
N/A
Net Income
-50.2M
EPS (Diluted)
$-5.49
Free Cash Flow
-45.2M
Total Assets
19.6M
Cash
2.6M
Profitability Ratios
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
ROE
-509.9%
ROA
-256.3%
FCF Margin
N/A
Balance Sheet & Liquidity
Current Ratio
2.97x
Quick Ratio
2.97x
Debt/Equity
0.20x
Debt/Assets
49.7%
Interest Coverage
-2,001.08x
Long-term Debt
2.0M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-04-15T01:12:21.657151 |
Data as of: 2025-12-31 |
Powered by Claude AI